Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
SEOVF SERNOVA CORPORATION
0.641
-0.016-2.44%
YOY
Do not show
Hide blank lines
(Q3)2022/07/31(Q2)2022/04/30(Q1)2022/01/31(FY)2021/10/31
Total revenue
0 0 0 0
Operating revenue
-- 0 -- 0 -- 0 -- 0
Cost of revenue
Gross profit
Operating expense
261.13% 5.91M 194.33% 4.93M 368.19% 5.46M 31.88% 6.94M
Selling and administrative expenses
179.58% 1.9M 209.64% 1.75M 368.37% 2.28M -7.66% 2.29M
-General and administrative expense
179.58% 1.9M 209.64% 1.75M 368.37% 2.28M -7.66% 2.29M
Research and development costs
318.56% 4.01M 186.02% 3.18M 367.29% 3.17M 68.13% 4.64M
Depreciation amortization depletion
636.74% 7.78K 1,202.23% 7.61K 1,405.78% 7.56K -60.71% 8.24K
-Depreciation and amortization
636.74% 7.78K 1,202.23% 7.61K 1,405.78% 7.56K -60.71% 8.24K
Operating profit
-261.13% -5.91M -194.33% -4.93M -368.19% -5.46M -31.88% -6.94M
Net non-operating interest income expense
372.30% 106.18K -77.32% 4.7K 101.00% 3.12K 125.69% 12.18K
Non-operating interest income
413.82% 120.1K -23.74% 19.88K 376.66% 19.51K 81.59% 70.55K
Non-operating interest expense
1,460.43% 13.92K 183.78% 15.19K -94.85% 16.38K -32.35% 58.37K
Other net income (expense)
-60.04% -26.73K 184.67% 9.61K 60.78% -5.07K -191.92% -41.22K
Gain on sale of security
-60.04% -26.73K 184.67% 9.61K 60.78% -5.07K -191.92% -41.22K
Income before tax
-257.54% -5.83M -195.13% -4.92M -265.82% -5.46M -30.90% -6.97M
Income tax
Net income
-257.54% -5.83M -195.13% -4.92M -265.82% -5.46M -30.90% -6.97M
Net income continuous Operations
-257.54% -5.83M -195.13% -4.92M -265.82% -5.46M -30.90% -6.97M
Minority interest income
Net income attributable to the parent company
-257.54% -5.83M -195.13% -4.92M -265.82% -5.46M -30.90% -6.97M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-257.54% -5.83M -195.13% -4.92M -265.82% -5.46M -30.90% -6.97M
Basic earnings per share
-100.00% -0.02 -100.00% -0.02 -100.00% -0.02 25.00% -0.03
Diluted earnings per share
-100.00% -0.02 -100.00% -0.02 -100.00% -0.02 25.00% -0.03
Dividend per share
Currency Unit
CADCADCADCAD
Audit Opinions
------Unqualified Opinion

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Sernova Corp. is a clinical stage regenerative medicine company. It engages in the business of developing medical technologies for the treatment of chronic debilitating metabolic diseases such as diabetes, blood disorders including hemophilia and other diseases treated through replacement of proteins and hormones missing within the body. The firm also focuses in the manufacture and clinical evaluation of the cell pouch for insulin-dependent diabetes. The company was founded on August 19, 1998 and is headquartered in London, Canada.
CEO: Dr. Philip M. Toleikis
Market: Pink Market
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist